MedPath

Evaluation of intervention strategies to manage fatigue during active treatment and to prevent persistent fatigue after curative treatment for cancer

Completed
Conditions
Cancer, curative treatment, fatigue
Cancer
Fatigue in cancer patients
Registration Number
ISRCTN20583070
Lead Sponsor
niversity Medical Centre St. Radboud (The Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
300
Inclusion Criteria

1. Patients just have been diagnosed for breast cancer, colorectal cancer, cervix cancer, uterus cancer, testis cancer, Hodgkin and non-Hodgkin disease
2. Patients in preparation of receiving therapy with curative intention (chemotherapy, radiotherapy and/or surgery)
3. 18 to 70 years old
4. Patients must be able to speak and write Dutch and to fill out the questionnaires independently
5. Patients have no somatic co-morbidity unrelated to the malignancy, that can co-exist with fatigue

Exclusion Criteria

Does not comply with the above inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fatigue severity will be measured using the Checklist Individual Strength. The Checklist Individual Strength is a 20-item questionnaire, designed to measure four aspects of fatigue over the last 14 days, namely: <br>1. Fatigue severity (eight items)<br>2. Concentration (five items)<br>3. Motivation (four items)<br>4. Physical activity (three items)<br><br>Each item is scored on a seven-point Likert scale. High scores indicate a high level of fatigue, a high level of concentration problems, low motivation and a low level of activity. Psychometric properties are excellent. A score of 35 or higher on the subscale fatigue severity indicates severe feelings of fatigue. Norm scores of different patients groups and healthy controls are available.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath